Clinical Trial Update: A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating tolerability, safety, and pharmacokinetics of AST-201 in patients with GPC3-positive advanced solid tumors; the trial is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Neoplasms
• Non-small Cell Lung Cancer

Drugs mentioned

• AST-201

Snippet

Sponsor: Aptamer Sciences, Inc. | Conditions: Neoplasms, Carcinoma, Hepatocellular | Phase 1 | Status: RECRUITING